Sampath-Kumar Anandan
18Patents
6h-index
31Co-inventors
66Inventor score
Filing activity: Aug 15, 2003 → Apr 17, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7345043B2 | Inhibitors of histone deacetylase | Chemistry; Metallurgy | 14 | Expired |
| US10278957B2 | Opioid agonist peptides and uses thereof | Chemistry; Metallurgy | 13 | Active |
| US10407468B2 | Methods for synthesizing α4β7 peptide antagonists | Human Necessities | 11 | Active |
| US10729676B2 | Opioid agonist peptides and uses thereof | Chemistry; Metallurgy | 8 | Active |
| US7772245B2 | Inhibitors of histone deacetylase | Chemistry; Metallurgy | 7 | Active |
| US7199106B2 | Lincomycin derivatives possessing antimicrobial activity | Chemistry; Metallurgy | 7 | Expired |
| US7361743B2 | Lincomycin derivatives possessing antibacterial activity | Human Necessities | 6 | Expired |
| US7199105B2 | Lincomycin derivatives possessing antibacterial activity | Chemistry; Metallurgy | 5 | Expired |
| US7164011B2 | Lincomycin derivatives possessing antibacterial activity | Chemistry; Metallurgy | 4 | Expired |
| US7256177B2 | Lincomycin derivatives possessing antibacterial activity | Chemistry; Metallurgy | 4 | Expired |
| US11339126B2 | Compounds for the reducing lipotoxic damage | Human Necessities | 3 | Active |
| US9556216B2 | 2′-Ethynyl nucleoside derivatives for treatment of viral infections | Chemistry; Metallurgy | 1 | Active |
| US11827619B2 | Dichlorophenol HSD17B13 inhibitors and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US9814739B2 | 2′-ethynyl nucleoside derivatives for treatment of viral infections | Chemistry; Metallurgy | 1 | Active |
| US12325690B2 | Compounds for the reducing lipotoxic damage | Human Necessities | 0 | Active |
| US11623915B2 | Compounds for the reducing lipotoxic damage | Human Necessities | 0 | Active |
| US12227489B2 | Dichlorophenol HSD17B13 inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11976040B2 | Compounds for the reducing lipotoxic damage | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.